If you’re one of the millions of Australians who’ve reached for a Codral, Sudafed, or Benadryl product to combat a nasty cold or flu, you might be shocked to learn that a law firm is taking pharmaceutical giant Johnson & Johnson to court over allegations that these meds just don’t work as promised.
The Allegations: “Ineffective” Products Sold to Unsuspecting Australians
JGA Saddler, the law firm behind the class action, claims that Johnson & Johnson has knowingly sold “ineffective” cold and flu products to Aussies over the past 18 years. The products in question contain phenylephrine, a drug marketed as a decongestant for years. However, new evidence in the United States has led the Food and Drugs Administration to consider banning the drug because it’s deemed ineffective when taken orally.
“Customers Have a Right to Know the Truth”
Rebecca Jancauskas, director of JGA Saddler, is adamant that customers have a right to know the truth about the products they’re buying. “Customers should be able to confidently buy medicines that work as advertised,” she said. “When they don’t, the company involved should be held accountable.”
A “David vs. Goliath” Battle for Aussie Consumers
This lawsuit is a major victory for Aussie consumers who’ve been misled by false promises. As Dr. Jo-Lyn McKenzie, a Brisbane ear, nose, and throat specialist, put it, “It’s unconscionable and deeply unethical for corporations to sell products knowing they don’t work.” She urges consumers to be cautious and informed, taking the time to have meaningful conversations with health professionals who can provide evidence-based recommendations.
Which Products Are Affected?
The class action covers a total of 20 Johnson & Johnson products, including:
- 12 Codral products
- 6 Sudafed products
- 3 Benadryl products
Have You Been Affected?
If you’ve purchased any of these products between 2005 and December 2024, you may be eligible to join the class action. Register now at coldandfluclassaction.com.au